Literature DB >> 23957520

An adaptive two-stage dose-response design method for establishing proof of concept.

Yoko Franchetti1, Stewart J Anderson, Allan R Sampson.   

Abstract

We propose an adaptive two-stage dose-response design where a prespecified adaptation rule is used to add and/or drop treatment arms between the stages. We extend the multiple comparison procedures-modeling (MCP-Mod) approach into a two-stage design. In each stage, we use the same set of candidate dose-response models and test for a dose-response relationship or proof of concept (PoC) via model-associated statistics. The stage-wise test results are then combined to establish "global" PoC using a conditional error function. Our simulation studies showed good and more robust power in our design method compared to conventional and fixed designs.

Entities:  

Mesh:

Year:  2013        PMID: 23957520      PMCID: PMC4073119          DOI: 10.1080/10543406.2013.813519

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  13 in total

1.  Combining different phases in the development of medical treatments within a single trial.

Authors:  P Bauer; M Kieser
Journal:  Stat Med       Date:  1999-07-30       Impact factor: 2.373

2.  Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives.

Authors:  H Derendorf; B Meibohm
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

3.  Adaptive dose-finding: Proof of concept with type I error control.

Authors:  Frank Miller
Journal:  Biom J       Date:  2010-10       Impact factor: 2.207

4.  Combining multiple comparisons and modeling techniques in dose-response studies.

Authors:  F Bretz; J C Pinheiro; M Branson
Journal:  Biometrics       Date:  2005-09       Impact factor: 2.571

5.  Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working Group.

Authors:  Paul Gallo; Christy Chuang-Stein; Vladimir Dragalin; Brenda Gaydos; Michael Krams; José Pinheiro
Journal:  J Biopharm Stat       Date:  2006-05       Impact factor: 1.051

6.  Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts.

Authors:  Frank Bretz; Heinz Schmidli; Franz König; Amy Racine; Willi Maurer
Journal:  Biom J       Date:  2006-08       Impact factor: 2.207

7.  Design and analysis of dose-finding studies combining multiple comparisons and modeling procedures.

Authors:  José Pinheiro; Björn Bornkamp; Frank Bretz
Journal:  J Biopharm Stat       Date:  2006       Impact factor: 1.051

8.  Adaptive designs for pivotal trials: discussion points from the PSI Adaptive Design Expert Group.

Authors:  Alan J Phillips; Oliver N Keene
Journal:  Pharm Stat       Date:  2006 Jan-Mar       Impact factor: 1.894

Review 9.  Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.

Authors:  B Meibohm; H Derendorf
Journal:  Int J Clin Pharmacol Ther       Date:  1997-10       Impact factor: 1.366

10.  Evaluation of experiments with adaptive interim analyses.

Authors:  P Bauer; K Köhne
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.